- Home
- RARE vs YETI Comparison
RARE vs YETI Comparison
Compare RARE & YETI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RARE | YETI |
|---|---|---|
| Founded | 2010 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Recreational Games/Products/Toys |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 3.1B |
| IPO Year | 2013 | 2016 |
Fundamental Metrics
Financial Performance| Metric | RARE | YETI |
|---|---|---|
| Price | $30.77 | $51.21 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 20 | 12 |
| Target Price | ★ $59.10 | $47.75 |
| AVG Volume (30 Days) | ★ 1.8M | 1.4M |
| Earning Date | 05-05-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 7.31 | N/A |
| EPS | N/A | ★ 0.13 |
| Revenue | $673,000,000.00 | ★ $1,868,494,000.00 |
| Revenue This Year | $13.12 | $9.07 |
| Revenue Next Year | $37.80 | $7.11 |
| P/E Ratio | ★ N/A | $390.46 |
| Revenue Growth | ★ 20.13 | 2.11 |
| 52 Week Low | $18.29 | $30.51 |
| 52 Week High | $39.98 | $51.89 |
Technical Indicators
Market Signals| Indicator | RARE | YETI |
|---|---|---|
| Relative Strength Index (RSI) | 73.20 | 61.82 |
| Support Level | $29.57 | $43.59 |
| Resistance Level | $34.01 | $51.89 |
| Average True Range (ATR) | 1.26 | 1.80 |
| MACD | 0.65 | -0.11 |
| Stochastic Oscillator | 90.71 | 73.57 |
Price Performance
Historical ComparisonAbout RARE Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. The company identifies, acquires, develops, and commercializes novel products for the treatment of serious, rare, and ultra-rare diseases, with a focus on debilitating genetic conditions. Its medicine portfolio includes Crysvita, Dojolvi, and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients aged one year and older. Mepsevii is indicated for pediatric and adult patients for the treatment of Mucopolysaccharidosis VII. The company operates across North America, Latin America, Europe, the Middle East and Africa, and Asia-Pacific, with the majority of its revenue generated from North America.
About YETI YETI Holdings Inc.
YETI Holdings Inc is a designer, marketer, and distributor of premium products for the outdoor and recreation market sold under the YETI brand. The company offers products including coolers and equipment, drinkware, and other accessories. Its trademark products include YETI Tundra, Hopper, YETI TANK, Rambler, Colster, Rambler among others. The company distributes products through wholesale channels and through direct-to-consumer, or DTC, channels.